检索

标题
作者
Clinical and laboratory methods for estimation the stage of fibrosis in case of chronic liver diseases
Medvedev Y., Bakulin I.
Patient with non-alcoholic fatty liver disease at care encounter of a therapist: Aspects of diagnostics and treatment
Turkina S., Statsenko M., Kosivtsova M., Titarenko M., Tyshchenko I.
COVID-19 and alcohol liver disease (literature review)
Usanova A., Novikova E., Kuzma F., Sergutova N.
Grishmanovskaya O.N. Possibilities for diagnostics of non-alcoholic fatty liver disease in patients with metabolically associated comorbid pathology
Aryamkina O., Dobrynina I., Biek A., Saitov A., Tarasova L., Zapevalov A., Grishmanovsky P., Grishmanovskaya O.
Clinical estimation of liver functional tests
Yakovenko E., Strokova T., Yakovenko A., Kuvaev R., Ivanov A., Bagaeva M.
Liver cirrhosis: modern approaches to diagnosis and treatment
Shchyokotova A.
Etiopathogenesis and possibilities of minimally invasive diagnostics of chronic diffuse liver diseases: literature review
Bulatova I., Shchekotova A., Paducheva S., Gulyaeva I., Sobol A.
Therapy of non-alcoholic liver steatosis as an important factor in the prevention of complications of non-alcoholic fatty liver disease
Tarasova L., Tsyganova Y.
Perspectives of use outside diabetes, cardiac and nephroprotection
Prikhodko V., Okovity S., Kulikov A.
Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment (clinical guidelines for therapists, third version)
Lazebnik L.
Prognostication of non-alcoholic fatty liver disease in people of young age
Pankova E., Chulkov V., Ektova N.
Immunological aspects of acute kidney injury in patients with liver cirrhosis
Karzakova L., Ivanova A., Abyzov I., Sidorov I., Tarasova L., Odintsova A.
Cardiovascular and metabolic risks in patients with obesity and non-alcoholic fatty liver disease
Kislyak O., Mikaelyan A., Starodubova A., Kosyura S.
Non-invasive assessment of liver abnormalities in patients with psoriatic arthritis
Mukhametshina E., Kirillova E., Fairushina I., Abdulganieva D.
Ammonia as an actual problem of a doctor and patient in therapeutic practice
Golovanova E.
CLINICAL CASE OF WILSON-KONOVALOV DISEASE
Eremina E.
The significance of non-alcoholic fatty liver disease in atrial fibrillation development: view of cardiologist
Tarzimanova A.
Neuropsychiatric disorders of non-alcoholic fatty liver disease
Prikhodko V., Okovity S.
Polymorphism of cytokine genes in patients with liver cirrhosis
Bulatova I., Shevlyukova T., Shchekotova A., Paducheva S., Martynov A.
Liver fibrosis assessment in long-term therapy with nucleos(t)ide analogues in chronic hepatitis B
Panevkina S., Abdurakhmanov D., Ibragimov E., Rozina T., Nikulkina E., Tanaschuk E., Odintsov A., Moiseev S.
Hypoxic hepatitis as a manifestation of a new coronavirus infection
Abyzov A., Tarasova L., Busalaeva E.
Fatal cases of chronic hepatitis delta: clinical, biochemical and virological characteristics
Isaeva O., Kyuregyan K., Ilchenko L., Karlsen A., Asadi Mobarkhan F., Saryglar A., Mikhailov M.
Polycystic liver and kidney disease
Mukhametova D., Odintsova A., Kirshin A., Kirshina A., Khasanshina A., Garaeva A., Mardanov I., Abdulganieva D.
Non-alcoholic fatty liver disease and atherosclerosis: common mechanisms of development and progression
Kuznetsova A., Genkel V., Dolgushina A., Shaposhnik I., Olevskaya E., Selyanina A., Khusainova G.
The contribution of the polymorphism of MMR 12 (rs652483) and PPARG (rs1801282) genes to the formation of NAFLD in obese patients
Shulkina S., Erbes P., Smirnov E.
Thrombotic complications in patients with liver cirrosis: current state of the problem
Osadchuk A., Osadchuk M., Zolotovskaya I.
Predictive value of studying lipopolysaccharide -binding protein in liver cirrhosis
Levitan B., Kasyanova T., Voloshina O., Martynova A.
Potentials for the additional medical correction cytoprotectors in patients with chronic heart fa and nonalcoholic fatty liver disease
Statsenko M., Turkina S., Shilina N., Kosivtsova M.
Family of selectins in non-alcoholic fatty liver disease
Koroy P., Kravchenko Y., Yagoda A.
APPLICATIONS OF REMAXOL IN HEPATOTOXIC LESIONS
Ilchenko L., Oskanova R., Fedorov I.
Obesity, non-alcoholic fatty liver disease, and FTO oligonucleotide polymorphism
Geyvandova T., Rogova S.
Defeat of the hepatobiliary system as the cause of death of the patient with COVID-19
Busalaeva E., Abyzov A., Tarasova L., Sergeev A., Ivanov A.
1 - 32 的 32 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##